awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37354067-95B63501-BD39-47E9-9532-3AC70EFDC969
Q37354067-95B63501-BD39-47E9-9532-3AC70EFDC969
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37354067-95B63501-BD39-47E9-9532-3AC70EFDC969
The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations.
P2860
Q37354067-95B63501-BD39-47E9-9532-3AC70EFDC969
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37354067-95B63501-BD39-47E9-9532-3AC70EFDC969
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
616582aaf3826881b297eaf98b955605ab4dd3a2
P2860
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.